| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |